A source tells Inside Health Policy that rumored potential HHS secretary nominee, former Lilly president and HHS official Alex Azar, has been interviewed for the job and wants it with conditions -- but those conditions remain unknown as of press time.
Forgot password?
Sign up today and your first download is free.
REGISTER
Drug Pricing
October 18, 2017 |
Daily News
October 17, 2017 |
Daily News
Senate health committee Chair Lamar Alexander (R-TN) questioned the merit of drug rebates at a hearing Tuesday (Oct. 17) on drug prices.
October 16, 2017 |
Daily News
Watchdog group Democracy Forward sued the White House Office of Management and Budget for information on the role OMB Associate Director of Health Programs Joseph Grogan played in the delays of the Obama administration's 340B drug ceiling price and manufacturer penalty rule.
October 16, 2017 |
Daily News
President Donald Trump on Monday (Oct. 16) renewed his promise to rein in the cost of prescription drugs.
October 13, 2017 |
Daily News
FDA announced Friday (Oct. 13) that it is expediting reviews and approvals of alternative dosage forms and generic versions of multiple critical drugs facing shortages following the hurricane in Puerto Rico.
October 12, 2017 |
Daily News
A coalition that includes the trade groups for the generic, hospital, health insurance and pharmacy benefit manager industries are the latest to call on Congress to investigate Allergan's deal with a Mohawk tribe to skirt inter partes review of its patents.
October 12, 2017 |
Daily News
A federal circuit judge has reversed a lower court's recent controversial decision to order a biologic cholesterol medication to be taken off the market in response to a patent challenge.
October 11, 2017 |
Daily News
Top pharmaceutical trade groups haven't yet said they will sue over California’s newly signed drug pricing law, but the generics trade group tells Inside Health Policy it is weighing its options.
October 11, 2017 |
Daily News
House Energy & Commerce Democrats on Wednesday (Oct. 11) touted 340B providers and the programs run off of savings received through that drug discount program, but committee Chair Greg Walden (R-OR) said he was worried about the lack of transparency and dearth of data on how the providers use the program.
October 11, 2017 |
Daily News
More than half of the Senate signed on to a letter asking CMS to make sure proposed cuts to hospitals' 340B drug reimbursement don't affect the long-term success of the program, though the bipartisan group says reforms to the 340B drug discount program are needed.
October 10, 2017 |
Daily News
The Fourth Circuit has granted the Association for Accessible Medicines’ request to expedite appeal of a district court’s recent decision to strike down a constitutional challenge to Maryland’s first-in-the-nation generic drug price gouging law.
October 10, 2017 |
Daily News
A bipartisan group of 54 House lawmakers on Oct. 3 asked CMS to force plans and pharmacy benefit managers to give Part D beneficiaries a larger share of rebates, discounts and pharmacy price concessions.
October 10, 2017 |
Daily News
The White House Office of Management and Budget is reviewing a proposed rule on 340B ceiling prices and manufacturer penalties following the Trump administration's fourth delay of a final rule on the same topic put out by the Obama administration.
October 06, 2017 |
Daily News
One key Democratic senator has introduced a bill that would strip tribes of their sovereign immunity under the inter partes review process, which if passed would effectively kill the idea of selling drug patents to tribes in an effort to shield those patents from the IPR process.
October 05, 2017 |
Daily News
House Energy & Commerce oversight Chair Tim Murphy's (R-PA) announcement Thursday (Oct. 5) he will resign this month comes as the subcommittee steps up its probe into the 340B drug discount program and investigates the healthcare industry's response to malware threats.
October 05, 2017 |
Daily News
Specialists are getting help from House Republican lawmakers in their quest to exclude the cost of drugs they administer from the calculation of their Medicare bonuses and penalties.
October 05, 2017 |
Daily News
The Senate health committee will hold the second of three planned hearings on drug pricing and the drug delivery system Tuesday Oct. 17, the committee announced Thursday (Oct. 5).
October 05, 2017 |
Daily News
The House Energy & Commerce oversight subcommittee is continuing its investigation into the 340B drug discount program with another hearing Oct. 11 on how providers use the program, the committee announced Wednesday (Oct. 4).
October 04, 2017 |
Daily News
FDA approved a record number of generic applications in fiscal 2017, according a former FDA official's analysis of data released Wednesday (Oct. 4).
October 04, 2017 |
Daily News
FDA released draft guidance this week aimed at facilitating development of one class of high-cost, widely sold complex drugs that currently lack generic competition.
Pages
© 2002-2017. Inside Washington Publishers